Important Risk Information DUO-FLOW® Indications for Use: The Medcomp® Duo-Flow® Catheter is indicated for use in attaining Short-Term vascular access for Hemodialysis and Apheresis. It may be inserted percutaneously and is primarily placed in the internal jugular vein of an adult patient. Alternate insertion sites include subclavian vein or femoral vein as required. The curved DuoFlow® Catheter is intended for internal jugular vein insertion. This catheter is indicated for a duration less than (30) days. For femoral placement, monitor catheter condition closely. Contraindications: This catheter is intended for Short-Term vascular access only and should not be used for any purpose other than indicated in these instructions. DUO-FLOW® 400XL Indications for Use: The Medcomp® Duo-Flow and Duo-Flow 400XL Double Lumen Catheters are designed for acute hemodialysis and apheresis. They may be inserted percutaneously and are ideally placed in the internal jugular vein. Although these catheters may be inserted into the subclavian or femoral vein, the internal jugular is the preferred site. Contraindications: This catheter is intended for Short-Term vascular access only and should not be used for any purpose other than indicated in these instructions. DUO-FLOW® SIDE X SIDE Indications for Use: The Medcomp® Side by Side Double Lumen Catheter is designed for acute hemodialysis and apheresis. It may be inserted percutaneously and is ideally placed in the jugular vein. Although this catheter may be inserted into the subclavian or femoral, the internal jugular is the preferred site. This catheter is indicated for a duration less than (30) days. Contraindications: This catheter is not intended for any use other than that which is indicated. Do not implant catheter in thrombosed vessels. DUO-FLOW® SOFT-LINE® Indications for Use: The Medcomp® Soft-Line® Catheter is indicated for use in attaining Short-Term vascular access for Hemodialysis and Apheresis. It may be inserted percutaneously and is primarily placed in the internal jugular vein of an adult patient. Alternate insertion sites include subclavian vein or femoral vein as required. The curved SoftLine® Catheter is intended for internal jugular vein insertion. This catheter is indicated for a duration less than (30) days. For femoral placement, monitor catheter condition closely. Contraindications: This catheter is intended for Short-Term vascular access only and should not be used for any purpose other than indicated in these instructions. DUO-SPLIT® Indications for Use: The Medcomp® Duo-Split® Double Lumen Catheter is indicated for use in attaining Short-Term vascular access for Hemodialysis and Apheresis. It may be inserted percutaneously and is primarily placed in the internal jugular vein of an adult patient. Alternate insertion sites include subclavian vein and femoral vein as required. The curved Duo-Split® Catheter is intended for internal jugular insertion. This catheter is indicated for a duration less than (30) days. Contraindications: This catheter is intended for Short-Term vascular access only and should not be used for any purpose other than indicated in these instructions. FREE-FLOW ST Indications for Use: The ST Catheter is indicated for use in attaining Short-Term vascular access for Hemodialysis, Hemofiltration, and Apheresis. It may be inserted percutaneously and is primarily placed in the internal jugular vein of an adult patient. Alternate insertion sites include the subclavian and femoral veins as required. This catheter is indicated for a duration less than (30) days. For femoral placement, monitor catheter condition closely. Contraindications: This catheter is intended for Short-Term vascular access only and should not be used for any purpose other than indicated in these instructions. HEMO-CATH® ST – SINGLE LUMEN Indications for Use: The Medcomp® Hemo-Cath® Silicone Single Lumen Catheter is designed for acute hemodialysis and apheresis. It may be inserted percutaneously and is ideally placed in the jugular vein. Although this catheter may be inserted into the subclavian or femoral, the internal jugular is the preferred site. This catheter is indicated for a duration less than (30) days. Contraindications: This catheter is not intended for any use other than that which is indicated. Do not implant catheter in thrombosed vessels. HEMO-CATH® ST – DOUBLE LUMEN Indications for Use: The Medcomp’s Hemo-Cath® Silicone Double Lumen Catheter can be utilized for temporary access for hemodialysis, hemoperfusion, or apheresis therapy. The cannula may be inserted via the Seldinger technique due to the inner stylet, increasing linear strength. The stylet is removed after insertion, leaving the soft silicone cannula in the body. The flexible silicone make-up conforms well to the vessel anatomy, resulting in higher patient tolerance during extended use. Contraindications: This catheter is intended for Short-Term vascular access only and should not be used for any purpose other than indicated in these instructions. SUBCLAVIAN Indications for Use: The Subclavian Catheter is designed for acute hemodialysis and apheresis. It may be inserted percutaneously and the preferred site is the subclavian vein. This catheter is indicated for a duration less than (30) days. Contraindications: This catheter is not intended for any use other than that which is indicated. Do not implant catheter in thrombosed vessels. TRI-FLOW Indications for Use: The Medcomp® Tri-Flow Catheter is indicated for use in attaining Short-Term vascular access for Hemodialysis and Apheresis. It may be inserted percutaneously and is primarily placed in the internal jugular vein of an adult patient. Alternate insertion sites include subclavian vein or femoral vein as required. The Medcomp® Tri-Flow Catheter is intended to be used less than (30) days. Contraindications: This catheter is intended for Short-Term vascular access only and should not be used for any purpose other than indicated in these instructions. Do not insert catheter in thrombosed vessels. T-3® CT Indications for Use: The Medcomp® T-3® CT Catheter is a triple lumen catheter indicated for use in attaining short-term vascular access for hemodialysis, apheresis. The third internal lumen is intended for infusion, power injection of contrast media and central venous pressure monitoring. The catheter is intended to be inserted in the jugular, femoral or subclavian vein as required. The maximum recommended infusion rate is 5ml/sec for power injection of contrast media. Contraindications: This catheter is intended for short-term (less than 30 days) vascular access only and should not be used for any purpose other than indicated in these instructions. This device is also contraindicated: When the presence of device related infection, bacteremia, or septicemia is known or suspected. When the patient’s body size is insufficient to accommodate the size of the implanted device. When the patient is known or is suspected to be allergic to materials contained in the device. If the prospective insertion site has been previously irradiated. If the prospective placement site has previously suffered episodes of venous thrombosis or vascular surgical procedures. If local tissue factors may prevent proper device stabilization and/or access. TRIO-CT® Indications for Use: The Trio-CT® Triple Lumen Catheter is indicated for use in attaining short-term (less than 30 days) vascular access for hemodialysis and apheresis. The third internal lumen is intended for infusion, power injection of contrast media and central venous pressure monitoring. The catheter is intended to be inserted in the jugular, femoral or subclavian vein as required. The maximum recommended infusion rate is 5ml/sec for power injection of contrast media. Contraindications: This catheter is intended for short-term (less than 30 days) vascular access only and should not be used for any purpose other than indicated in these instructions. This device is also contraindicated: When the presence of device related infection, bacteremia, or septicemia is known or suspected. When the patient’s body size is insufficient to accommodate the size of the implanted device. When the patient is known or is suspected to be allergic to materials contained in the device. If the prospective insertion site has been previously irradiated. If the prospective placement site has previously suffered episodes of venous thrombosis or vascular surgical procedures. If local tissue factors may prevent proper device stabilization and/or access. Refer to Instructions for Use for complete instructions, warnings, and contraindications. Observe all Instructions for Use prior to using products. Failure to do so may result in patient complications. For patient information please visit www.medcomp.net/patientinformation
RkJQdWJsaXNoZXIy MTYyNDM3Mw==